BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 27458175)

  • 1. Integrative Analysis of Microarray Data to Reveal Regulation Patterns in the Pathogenesis of Hepatocellular Carcinoma.
    Chen J; Qian Z; Li F; Li J; Lu Y
    Gut Liver; 2017 Jan; 11(1):112-120. PubMed ID: 27458175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of upstream transcription factors (TFs) for expression signature genes in breast cancer.
    Zang H; Li N; Pan Y; Hao J
    Gynecol Endocrinol; 2017 Mar; 33(3):193-198. PubMed ID: 27809618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of transcription factors (TFs) and targets involved in the cholangiocarcinoma (CCA) by integrated analysis.
    Yang L; Feng S; Yang Y
    Cancer Gene Ther; 2016 Dec; 23(12):439-445. PubMed ID: 27857060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases.
    Zhang P; Feng J; Wu X; Chu W; Zhang Y; Li P
    Pathol Oncol Res; 2021; 27():588532. PubMed ID: 34257537
    [No Abstract]   [Full Text] [Related]  

  • 5. Screening Driving Transcription Factors in the Processing of Gastric Cancer.
    Xu G; Li K; Zhang N; Zhu B; Feng G
    Gastroenterol Res Pract; 2016; 2016():8431480. PubMed ID: 27403158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of upstream regulators for synovial expression signature genes in osteoarthritis.
    Fei Q; Lin J; Meng H; Wang B; Yang Y; Wang Q; Su N; Li J; Li D
    Joint Bone Spine; 2016 Oct; 83(5):545-51. PubMed ID: 26832188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrative analysis of the molecular signature of target genes involved in the antitumor effects of cantharidin on hepatocellular carcinoma.
    Yan J; Gao YM; Deng XL; Wang HS; Shi GT
    BMC Cancer; 2023 Nov; 23(1):1161. PubMed ID: 38017425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Key signaling pathways, genes and transcription factors associated with hepatocellular carcinoma.
    Wang J; Tian Y; Chen H; Li H; Zheng S
    Mol Med Rep; 2018 Jun; 17(6):8153-8160. PubMed ID: 29658607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive network analysis of the molecular mechanisms associated with sorafenib resistance in hepatocellular carcinoma.
    Lin H; Zhang R; Wu W; Lei L
    Cancer Genet; 2020 Jul; 245():27-34. PubMed ID: 32559715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of
    Bai L; Ren Y; Cui T
    J Comput Biol; 2020 Jun; 27(6):965-974. PubMed ID: 31593490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
    Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
    Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of hepatocellular carcinoma-associated hub genes and pathways by integrated microarray analysis.
    Liu F; Li H; Chang H; Wang J; Lu J
    Tumori; 2015; 101(2):206-14. PubMed ID: 25768320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms of pathogenesis in hepatocellular carcinoma revealed by RNA‑sequencing.
    Liu Y; Yang Z; Du F; Yang Q; Hou J; Yan X; Geng Y; Zhao Y; Wang H
    Mol Med Rep; 2017 Nov; 16(5):6674-6682. PubMed ID: 28901494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the key transcription factors in esophageal squamous cell carcinoma.
    Zhang Y; Xu Y; Li Z; Zhu Y; Wen S; Wang M; Lv H; Zhang F; Tian Z
    J Thorac Dis; 2018 Jan; 10(1):148-161. PubMed ID: 29600044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Potentially Functional CircRNA-miRNA-mRNA Regulatory Network in Hepatocellular Carcinoma by Integrated Microarray Analysis.
    Lin X; Chen Y
    Med Sci Monit Basic Res; 2018 Apr; 24():70-78. PubMed ID: 29706616
    [TBL] [Abstract][Full Text] [Related]  

  • 16.  CUL4B, NEDD4, and UGT1As involve in the TGF-β signalling in hepatocellular carcinoma.
    Qu Z; Li D; Xu H; Zhang R; Li B; Sun C; Dong W; Zhang Y
    Ann Hepatol; 2016; 15(4):568-76. PubMed ID: 27236156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of differentially co-expressed genes based on microarray data of hepatocellular carcinoma.
    Wang Y; Jiang T; Li Z; Lu L; Zhang R; Zhang D; Wang X; Tan J
    Neoplasma; 2017; 64(2):216-221. PubMed ID: 28043148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of core genes and outcomes in hepatocellular carcinoma by bioinformatics analysis.
    Shen S; Kong J; Qiu Y; Yang X; Wang W; Yan L
    J Cell Biochem; 2019 Jun; 120(6):10069-10081. PubMed ID: 30525236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening key miRNAs for human hepatocellular carcinoma based on miRNA-mRNA functional synergistic network.
    Zhang CJ; Du HJ
    Neoplasma; 2017; 64(6):816-823. PubMed ID: 28895405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening and identification of key biomarkers in hepatocellular carcinoma: Evidence from bioinformatic analysis.
    Li L; Lei Q; Zhang S; Kong L; Qin B
    Oncol Rep; 2017 Nov; 38(5):2607-2618. PubMed ID: 28901457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.